LHLabcorp
$366.64+46% 1Y
$366.64
$244.6952 weeks$368.11
Growth
Is LH growing?
Labcorp's revenue has grown 6.6% a year over three years, with earnings per share compounding at 17%.
+6.6%
Revenue growth, 3-year annual rate · Diagnostics & Research median +9.4% · compounded from trailing twelve-month revenue
- Earnings per share, 3-year rate
- +17%
Earnings per share, 3-year rate · revenue +6.6% · earnings per share grew faster than revenue
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $13.1B
- Revenue FY2022
- $11.9B
- Revenue FY2023
- $12.2B
- Revenue FY2024
- $13.0B
- Revenue FY2025
- $14.0B
Annual income statements as filed with the SEC.
Where the revenue comes from
10 quarters, Mar 2024 to Jun 2026Diagnostics, quarter to Jun 2026from $2.48B in Mar 2024$2.90B
Diagnostics$2.90B
Biopharma Laboratory Services$836.2M
Operating metrics
From earnings releases, Q2 2023 to Q3 2026
Biopharma Labs backlog, Q3 2026+4.0% on a year ago$8.92B
+4.0% on a year ago
Trailing twelve-month net orders$3.59B
Q3 2026, +7.5% on a year ago
Biopharma Labs backlog, Q3 2026: $8.92B
Backlog8.92(7)
Source: Q3 2026 earnings release, filed Oct 28, 2026Diagnostics & Research
The closest names by size in the same industry